Greenstone methylprednisolone Dosepak recalled for labeling error
Greenstone LLC is recalling methylprednisolone 4 mg Dosepak tablets (Lot #LG7675, expiring November 2026) because the blister foil is oriented incorrectly. This misalignment can make the dosing directions on the foil confusing or unclear, which could lead to taking the wrong dose.
From the FDA notice · Read the official notice ↗
What to do
- Check your methylprednisolone Dosepak for Lot #LG7675 with November 2026 expiration.
- Contact your pharmacy or doctor for a replacement or instructions on returning the recalled medication.
- Do not use this medication if you have this lot number.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 3456 cartons
- Illnesses reported
- None reported
- Manufactured in
- 100 Route 206 North, N/A, Peapack, NJ, United States
- Classification
- Class II
- Recall number
- D-0299-2026
In the FDA's words
- Description
- methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2 Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil. Lot # LG7675, Exp. Date Nov 2026 Distribution: Nationwide within the United States Affected quantity: 3456 cartons
- Hazard
- Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.